Locally advanced NSCLC
/thumbnails/0.png)
91P - Prognosis of EGFR-mutant advanced lung adenocarcinoma patients with different intrathoracic metastatic patterns
Authors
- F. Hu (Shanghai, China)
- B. Zhang (Shanghai, China)
- C. Li (Shanghai, China)
- J. Xu (Shanghai, China)
- H. Wang (Shanghai, China)
- P. Gu (Shanghai, China)
- X. Zheng (Shanghai, China)
- W. Nie (Shanghai, China)
- Y. Shen (Shanghai, China)
- H. Zhang (Shanghai, China)
- P. Hu (Zhenjiang, China)
- X. Zhang (Shanghai, China)
Speakers
- F. Hu (Shanghai, China)
Advanced NSCLC
174P - NSCLC stages IIa-IIIc: Tumor related IGRT yields better local control than kV-guidance to anatomic structures
Authors
- F. Zehentmayr (Salzburg, Austria)
- J. Karner (Salzburg, Austria)
- R. Wass (Linz, Austria)
- K. Wurstbauer (Feldkirch, Austria)
- G. Fastner (Salzburg, Austria)
- L. Rettenbacher (Salzburg, Austria)
- M. Studnicka (Salzburg, Austria)
- C. Pirich (Salzburg, Austria)
- P. Kopp (Salzburg, Austria)
- F. Sedlmayer (Salzburg, Austria)
Speakers
- F. Zehentmayr (Salzburg, Austria)
Early stage NSCLC
74P - Is there any prognostic significance of the level of change in SUVmax after SBRT in patients with early stage NSCLC?
Authors
- G. Yaprak (Istanbul, Turkey)
- A. Ozen (Eskisehir, Turkey)
- F. Tugrul (Eskisehir, Turkey)
- S. Ozugur (Istanbul, Turkey)
- N. Isik (Istanbul, Turkey)
Speakers
- G. Yaprak (Istanbul, Turkey)
Tumour biology and pathology
14P - The characteristics of MET exon 14 skipping mutations in Chinese non-small cell lung cancer: A retrospective analysis
Authors
- Y. Zhu (Zhenjiang, China)
- C. Xu (Fuzhou, China)
- W. Wang (Zhenjiang, China)
- Q. Zhang (Fuzhou, China)
- W. Zhuang (Fuzhou, China)
- G. Chen (Fuzhou, China)
- M. Fang (Zhenjiang, China)
- T. Lv (Nanjing, China)
- Y. Song (Nanjing, China)
Speakers
- Y. Zhu (Zhenjiang, China)
Tumour biology and pathology
12P - Clinicopathologic characteristics of patients with TP63 mutations in Chinese non-small cell lung cancer
Authors
- Q. Zhang (Fuzhou, China)
- C. Xu (Fuzhou, China)
- W. Wang (Zhenjiang, China)
- W. Zhuang (Fuzhou, China)
- Z. Huang (Fuzhou, China)
- G. Chen (Fuzhou, China)
- M. Fang (Zhenjiang, China)
- T. Lv (Nanjing, China)
- Y. Song (Nanjing, China)
Speakers
- Q. Zhang (Fuzhou, China)
Tumour biology and pathology
10P - The prevalence and prognostic significance of JAK2 mutation subtypes in non-small cell lung cancer from Chinese populations
Authors
- W. Wang (Zhenjiang, China)
- C. Xu (Fuzhou, China)
- Q. Zhang (Fuzhou, China)
- W. Zhuang (Fuzhou, China)
- Y. Zhu (Zhenjiang, China)
- Z. Huang (Fuzhou, China)
- G. Chen (Fuzhou, China)
- M. Fang (Zhenjiang, China)
- T. Lv (Nanjing, China)
- Y. Song (Nanjing, China)
Speakers
- W. Wang (Zhenjiang, China)
Advanced NSCLC
138P - PD-L1 confers primary resistance to EGFR-TKI in EGFR mutant non-small cell lung cancer via inducing EMT phenotype
Authors
- Y. Zhang (Suzhou, China)
- T. Liu (Suzhou, China)
- Y. Zeng (Suzhou, China)
- J. Zhu (Suzhou, China)
- W. Du (Suzhou, China)
- L. Zeyi (Suzhou, China)
- J. Huang (Suzhou, China)
Speakers
- Y. Zhang (Suzhou, China)
Advanced NSCLC
137P - Detection and clinicopathologic features of ctDNA in T790M-positive advanced lung adenocarcinomas patients after failure of treatment with first- and second-generation EGFR-TKIs
Authors
- W. He (Nanning, China)
- Z. Zhou (Nanning, China)
- T. Yu (Nanning, China)
- H. Zhao (Nanning, China)
- Y. Su (Nanning, China)
- P. Zeng (Nanning, China)
Speakers
- W. He (Nanning, China)
Early stage NSCLC
78P - Lung resection for cancer in patients with heart disease: Management and postoperative outcome
Authors
- F. Caushi (Tirana, Albania)
- I. Skenduli (Tirana, Albania)
- A. Hatibi (Tirana, Albania)
- A. Mezini (Tirana, Albania)
- S. Telo (Tirana, Albania)
- S. Bala (Tirana, Albania)
- E. Shima (Tirana, Albania)
- A. Cani (Tirana, Albania)
Speakers
- F. Caushi (Tirana, Albania)
Advanced NSCLC
129P - Anlotinib can overcome acquired resistance to EGFR-TKIs via FGFR1 signaling in non-small cell lung cancer
Authors
- Z. Lian (Suzhou, China)
- W. Du (Suzhou, China)
- J. Zhu (Suzhou, China)
- Y. Zeng (Suzhou, China)
- L. Zeyi (Suzhou, China)
- J. Huang (Suzhou, China)
Speakers
- Z. Lian (Suzhou, China)
Advanced NSCLC
164P - PD-L1 expression affect the efficacy of pemetrexed maintenance therapy in real-world patients with advanced non-squamous NSCLC
Authors
- Y. Qin (Chengdu, China)
- L. Jiang (Chengdu, China)
- Y. Li (Chengdu, China)
- L. Ren (Chengdu, China)
- Y. Wang (Chengdu, China)
- Y. Gong (Chengdu, China)
- F. Peng (Chengdu, China)
- J. Zhu (Chengdu, China)
- Z. Ding (Chengdu, China)
- Y. Liu (Chengdu, China)
- M. Yu (Chengdu, China)
- Y. Lu (Chengdu, China)
- M. Huang (Chengdu, China)
Speakers
- Y. Qin (Chengdu, China)
Advanced NSCLC
130P - Relationship of clinicopathological characteristics, EGFR genotyping and prognosis in non-small cell lung cancer patients with malignant pleural effusion
Authors
- J. Zhang (Nanning, China)
- Z. Zhou (Nanning, China)
- Y. Su (Nanning, China)
- T. Yu (Nanning, China)
Speakers
- J. Zhang (Nanning, China)